Similar Search Results

Should product-specific advertisement be regulated in pharmaceutical markets?

Ishida, Junichiro; Takahara, Tsuyoshi - In: Journal of public economic theory 26 (2024) 2, pp. 1-37

Persistent link: https://www.econbiz.de/10014507649

The Effect of Price Caps on Pharmaceutical Advertising : Evidence from the 340b Drug Pricing Program

Hristakeva, Sylvia; Mortimer, Julie Holland; Yde, Eric - National Bureau of Economic Research - 2024

We study the effect of price caps on the provision of costly effort by pharmaceutical firms using variation in drug discounts generated by a price regulation program that allows eligible hospitals to purchase outpatient drugs at steep discounts. These discounts directly affect drug...

Persistent link: https://www.econbiz.de/10014512103

Smart advertising in prescription only medication : aligning it with prescriber's or consumer's behavior

Menebo, Mesay Moges - In: International journal of pharmaceutical and healthcare … 16 (2022) 1, pp. 55-74

Persistent link: https://www.econbiz.de/10012886102

Side Effects of Competition : the Role of Advertising and Promotion in Pharmaceutical Markets

David, Guy - 2011

The extent of pharmaceutical advertising and promotion can be characterized by a balancing act between profitable … scenarios and test the model's predictions using a novel combination of sales, promotion, advertising, and adverse event reports … health events, and have extensive advertising and promotion. We find that advertising and promotion expenditures increase own …

Persistent link: https://www.econbiz.de/10012461495

Mergers and advertising in the pharmaceutical industry

Dubois, Pierre; Majewska, Gosia - 2022

Persistent link: https://www.econbiz.de/10013449296

Digital Direct-to-Consumer Advertising : A Perfect Storm of Rapid Evolution and Stagnant Regulation; Comment on 'Trouble Spots in Online Direct-to-Consumer Prescription Drug Promot...

Mackey, Tim - 2016

The adoption and use of digital forms of direct-to-consumer advertising (also known as “eDTCA”) is on the rise. At the …

Persistent link: https://www.econbiz.de/10014128962

Pharmaceutical Promotion and Gp Prescription Behaviour

Windmeijer, Frank; de Laat, Eric; Douven, Rudy; Mot, Esther - 2006

The aim of this paper is to empirically analyse the responses by general practitioners to promotional activities for ethical drugs by pharmaceutical companies. Promotion can be beneficial as a means of providing information, but it can also be harmful in the sense that it lowers price...

Persistent link: https://www.econbiz.de/10014058923

Pharmaceutical Promotion and Gp Prescription Behaviour

Windmeijer, Frank; de Laat, Eric; Douven, Rudy; Mot, Esther - 2009

pharmaceuticals by pharmaceutical companies. Promotion can be beneficial as a means of providing information, but it can also be …

Persistent link: https://www.econbiz.de/10014072054

Just What the Patient Ordered? Direct-to-Consumer Advertising and the Demand for Pharmaceutical Products

Wosinska, Marta - 2002

? Empirical analysis of patient-level prescription claims reveals that direct-to-consumer advertising does impact the choice …. Consequently, advertising affects the treatment probability benefiting all competing brands. Second, advertising infleunces demand …

Persistent link: https://www.econbiz.de/10014103710

Should product-specific advertisement be regulated in pharmaceutical markets?

Ishida, Junichiro; Takahara, Tsuyoshi - 2022

This paper examines the optimal content regulation of DTCA by comparing two forms of DTCA-product-specific and category-specific-and identifies a key tradeoff which underlies this policy debate. Our analysis suggests that the optimal form of DTCA depends crucially on the cost effectiveness of...

Persistent link: https://www.econbiz.de/10013329470